Based on the above results, elevated expression of DHCR7 was observed in advanced stages and metastatic tissues of human cancers, which means DHCR7 might be an optimal prognostic, tumor progression, and novel therapeutic biomarker. This evidence concerns the gene DHCR7 and cancer.